Gabelli Funds LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Gabelli Funds LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.2 - $4.2 $165,000 - $315,000	-75,000 Reduced 82.25%	16,183 $39,000
Q1 2022 May 18, 2022	BUY	$2.83 - $8.69 $258,047 - $792,380	91,183 New	91,183 $367,000
Q1 2022 May 13, 2022	SELL	$2.83 - $8.69 $424,500 - $1.3 Million	-150,000 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$8.31 - $14.92 $1.25 Million - $2.24 Million	150,000 New	150,000 $1.25 Million

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $10.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

Stay updated on Gabelli Funds LLC with notifications on news.